Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)CAE Plus LAI in Individuals With Bipolar Disorder at Risk for Treatment Non-adherence (BD-CAEL)
Phase 4
Completed
- Conditions
- Medication Non AdherenceMedication AdherenceBipolar Disorder
- Interventions
- Behavioral: Customized Adherence Enhancement (CAE)
- First Posted Date
- 2018-01-24
- Last Posted Date
- 2022-02-17
- Lead Sponsor
- Martha Sajatovic
- Target Recruit Count
- 30
- Registration Number
- NCT03408873
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
News
No news found